Skip to content

Clinical trials

Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Clear all

13,469 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
2000122
2001144
2002172
2003203
2004263
2005303
2006390
2007415
2008455
2009447
2010445
2011413
2012433
2013441
2014492
2015570
2016569
2017555
2018546
2019642
2020597
2021717
2022742
2023748
2024746
2025773
2026680

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6,549
Unknown status1,885
Recruiting1,820
Terminated1,157
Active, not recruiting890
Not yet recruiting584
Withdrawn449
Enrolling by invitation73
Suspended43
No longer available7
Approved for marketing6
Available5
Temporarily not available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)288
Memorial Sloan Kettering Cancer Center234
Fudan University219
M.D. Anderson Cancer Center216
AstraZeneca174
Hoffmann-La Roche174
Novartis Pharmaceuticals164
Pfizer152
Dana-Farber Cancer Institute138
Mayo Clinic138

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms13,469
Neoplasms713
Ovarian Neoplasms598
Lung Neoplasms586
Neoplasm Metastasis547
Prostatic Neoplasms544
Colorectal Neoplasms533
Triple Negative Breast Neoplasms468
Carcinoma, Non-Small-Cell Lung385
Pancreatic Neoplasms349

Trials

Showing 51 to 75 of 13,469. Each trial links to its page on Pharma Observatory.

13,369 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.